# Enhabit, Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Enhabit, Inc.). ## Overview Enhabit, Inc. is a U.S. home health and hospice provider headquartered in Dallas, Texas, and spun out of Encompass Health in 2022. The company delivers Medicare-certified care in patients’ homes through two operating segments: Home Health and Hospice. ## Products & services • Skilled home health nursing and therapy • Medical social work and home health aide services • Hospice nursing, pain and symptom management • Palliative, dietary, spiritual and bereavement counseling • Care transition and referral-based post-acute services - **Home Health** (76.8%) — Skilled in-home medical care including nursing, therapy, social work, and aide support. - **Hospice** (23.2%) — End-of-life care services for terminally ill patients and family support. - Skilled home health nursing and therapy - Medical social work and home health aide services - Hospice nursing and symptom management - Palliative, dietary, spiritual and bereavement counseling - Care transition and referral-based post-acute services ## Customers Enhabit serves patients who need clinically managed care at home, typically after hospitalization, during recovery, or near end of life. Its payers are largely Medicare and Medicare Advantage plans, with referrals flowing from hospitals, physicians, and other healthcare providers. The business depends on patient volume, referral relationships, and reimbursement rates rather than direct consumer demand. - **Home Health patients** (primary) — Patients needing skilled nursing, therapy, and aide services at home after illness or hospitalization. - **Hospice patients** (primary) — Terminally ill patients and families buying symptom management and comfort-focused care. - **Medicare Advantage members** (secondary) — Managed-care patients whose volumes depend on contract terms and payer relationships. - **Referral sources** (primary) — Hospitals, physicians, and care coordinators that direct patients to Enhabit’s agencies. - Medicare beneficiaries needing skilled care at home - Hospice patients and families seeking end-of-life support - Medicare Advantage members covered under managed care contracts - Hospitals and physicians that refer post-acute patients - Families choosing home-based care over facility care ## Geography Enhabit operates entirely in the United States and had 249 home health locations and 117 hospice locations across 34 states as of year-end 2025. Its footprint is built around scale and density in selected local markets, with 111 hospice locations co-located within home health markets. Geography matters because reimbursement, referral access, and operating efficiency vary by state and by local market concentration. - **United States** (100%) — Company operates only in the U.S.; no country-level revenue split disclosed. - All revenue is generated in the United States - Operations span 34 states through home health and hospice branches - 249 home health locations support broad local referral coverage - 117 hospice locations extend end-of-life care within existing markets - 111 hospice sites are co-located with home health markets ## Strategy Enhabit is focused on growing volume in existing markets, opening new locations, and improving reimbursement through payer innovation and Medicare Advantage contracting. It is also emphasizing operating efficiency, including visits-per-episode management in home health, while preserving scale and density in markets where it already has a presence. - **Organic growth in existing markets** (short-term) — Higher referral density improves utilization, brand awareness, and operating leverage. - **De novo expansion** (medium-term) — New branches extend the footprint and create future scale in attractive markets. - **Payer mix and contract optimization** (medium-term) — Better reimbursement rates support margin stability in a regulated business. - **Cost and visit efficiency** (short-term) — Labor intensity and reimbursement pressure make productivity critical to profitability. - Grow referrals and volume in existing home health and hospice markets - Open de novo locations in new and existing markets - Shift Medicare Advantage business to better-paying contracts - Expand payer innovation contracts to improve reimbursement - Use visits-per-episode management to control home health costs ## Risks Enhabit faces reimbursement pressure, especially from Medicare and Medicare Advantage rate changes, and its results depend heavily on patient volume and referral flow. It also operates in a fragmented, highly competitive market where larger providers and managed care companies can pressure volumes and pricing. Labor shortages, regulatory scrutiny, litigation, and execution risk around acquisitions, de novo openings, and leadership transition add further downside risk. - **Medicare reimbursement pressure** [high] — Home health and hospice revenue is heavily tied to government payment updates and rule changes. - **Volume and referral decline** [high] — The business depends on referrals, quality scores, and hospital readmission performance. - **Competitive pressure from managed care and local providers** [medium] — Competitors may have stronger scale, relationships, or direct home health offerings. - **Labor shortages and wage inflation** [high] — Care delivery is labor intensive and staffing is central to service capacity and quality. - **Integration and expansion execution** [medium] — Acquisitions and de novo locations require approvals, capital, and operational integration. - **Leadership transition** [medium] — CEO transition can disrupt continuity, retention, and strategic execution. - Medicare and Medicare Advantage reimbursement can change annually - Patient volume depends on referrals and quality metrics - Competition is intense and includes larger providers and managed care firms - Labor inflation and staffing shortages raise operating costs - Acquisitions, de novo openings, and integration can miss targets - Goodwill and intangible assets may face further impairment ## Accounting Revenue recognition is driven by patient service delivery and payer reimbursement, so estimates around collectability, denials, and audits can materially affect reported net service revenue. The company also has meaningful non-cash accounting exposure from goodwill and intangible asset impairment, which already affected 2025 results, and from Medicare-related receivables and cap liabilities that can swing quarterly results. - **Revenue recognition and payer estimates** — Can affect net service revenue and receivables - **Accounts receivable reserves** — Affects bad debt-like expense and cash conversion - **Goodwill impairment** — Reduces earnings and may signal weaker long-term assumptions - **Other intangible asset impairment** — Can create non-cash charges and lower asset values - **Medicare cap liabilities** — Can cause volatility in quarterly hospice revenue and earnings - Net service revenue depends on payer estimates and reimbursement timing - Accounts receivable reserves reflect denials, audits, and collectability risk - Goodwill impairment can materially reduce earnings and equity - Other intangible assets and certificates of need may be impaired - Medicare cap liabilities and reversals can create quarter-to-quarter volatility --- *Last updated: 2026-04-28T20:04:59.422335+00:00*